A modified gene trap approach for improved high-throughput cancer drug discovery.

Abstract:

:While advances in laboratory automation has dramatically increased throughout of compound screening efforts, development of robust cell-based assays in relevant disease models remain resource-intensive and time-consuming, presenting a bottleneck to drug discovery campaigns. To address this issue, we present a modified gene trap approach to efficiently generate pathway-specific reporters that result in a robust "on" signal when the pathway of interest is inhibited. In this proof-of-concept study, we used vemurafenib and trametinib to identify traps that specifically detect inhibition of the mitogen-activated protein kinase (MAPK) pathway in a model of BRAFV600E driven human malignant melanoma. We demonstrate that insertion of our trap into particular loci results in remarkably specific detection of MAPK pathway inhibitors over compounds targeting any other pathway or cellular function. The accuracy of our approach was highlighted in a pilot screen of ~6000 compounds where 40 actives were detected, including 18 MEK, 10 RAF, and 3 ERK inhibitors along with a few compounds representing previously under-characterized inhibitors of the MAPK pathway. One such compound, bafetinib, a second generation BCR/ABL inhibitor, reduced phosphorylation of ERK and when combined with trametinib, both in vitro and in vivo, reduced growth of vemurafenib resistant melanoma cells. While piloted in a model of BRAF-driven melanoma, our results set the stage for using this approach to rapidly generate reporters against any transcriptionally active pathway across a wide variety of disease-relevant cell-based models to expedite drug discovery efforts.

journal_name

Oncogene

journal_title

Oncogene

authors

Morris SM,Mhyre AJ,Carmack SS,Myers CH,Burns C,Ye W,Ferrer M,Olson JM,Klinghoffer RA

doi

10.1038/s41388-018-0274-4

subject

Has Abstract

pub_date

2018-08-01 00:00:00

pages

4226-4238

issue

31

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-018-0274-4

journal_volume

37

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

    abstract::Prostate stem cell antigen (PSCA) is a recently defined homologue of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA mRNA is expressed in the basal cells of normal prostate and in more than 80% of prostate cancers. The purpose of the present study was to examine PSCA pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203426

    authors: Gu Z,Thomas G,Yamashiro J,Shintaku IP,Dorey F,Raitano A,Witte ON,Said JW,Loda M,Reiter RE

    更新日期:2000-03-02 00:00:00

  • Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

    abstract::Although cyclin D1 is overexpressed in a significant number of human cancers, overexpression alone is insufficient to promote tumorigenesis. In vitro studies have revealed that inhibition of cyclin D1 nuclear export unmasks its neoplastic potential. Cyclin D1 nuclear export depends upon phosphorylation of a C-terminal...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209644

    authors: Benzeno S,Lu F,Guo M,Barbash O,Zhang F,Herman JG,Klein PS,Rustgi A,Diehl JA

    更新日期:2006-10-12 00:00:00

  • Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

    abstract::The diverse checkpoint responses to DNA damage may reflect differential sensitivities by molecular components of the damage-signalling network to the type and amount of lesions. Here, we determined the kinetics of activation of the checkpoint kinases ATM and Chk2 (the latter substrate of ATM) in relation to the initia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207986

    authors: Buscemi G,Perego P,Carenini N,Nakanishi M,Chessa L,Chen J,Khanna K,Delia D

    更新日期:2004-10-07 00:00:00

  • Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.

    abstract::Normal human melanocytes are interspersed singly among keratinocytes along the basement membrane of the epidermis, whereas melanoma cells readily adhere to each other during invasion of the dermis or distant organs. The tumorigenic and metastatic phenotype of melanoma cells often correlates with increased expression o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204616

    authors: Satyamoorthy K,Muyrers J,Meier F,Patel D,Herlyn M

    更新日期:2001-08-02 00:00:00

  • Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.

    abstract::Aberrant protein glycosylation could be a distinct surface-marker of cancer cells that influences cancer progression and metastasis because glycosylation can regulate membrane protein folding which alters receptor activation and changes epitope exposure for antibody (Ab) recognition. Carcinoembryonic antigen-related c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.303

    authors: Chiang WF,Cheng TM,Chang CC,Pan SH,Changou CA,Chang TH,Lee KH,Wu SY,Chen YF,Chuang KH,Shieh DB,Chen YL,Tu CC,Tsui WL,Wu MH

    更新日期:2018-01-04 00:00:00

  • Delayed cyclin B1 expression during the G2 arrest following DNA damage.

    abstract::Exposure of cells to DNA damaging agents results in a G2 arrest. Exposure of HeLa cells to camptothecin, etoposide or nitrogen mustard for 1 h in S phase resulted in delayed expression of cyclin B1 mRNA during the G2 arrest. Initially the levels of cyclin B1 protein were low as well; however, with extended time the ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maity A,Hwang A,Janss A,Phillips P,McKenna WG,Muschel RJ

    更新日期:1996-10-17 00:00:00

  • Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells.

    abstract::Ret is a receptor tyrosine kinase predominantly expressed in tissue derived from the neuroectoderm and is involved in multiple endocrine neoplasia type 2A and 2B, familiar medullary thyroid carcinoma, and Hirschsprung's disease. The ligand for the receptor is still unknown. Previously, using a human epidermal growth f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: van Weering DH,Medema JP,van Puijenbroek A,Burgering BM,Baas PD,Bos JL

    更新日期:1995-12-07 00:00:00

  • Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice.

    abstract::The degree of DNA methylation in the c-fos gene and its vicinity in liver, brain and spleen of mice of different ages was examined using methylation-sensitive restriction endonucleases. The gene had an invariable unmethylated domain from 1.8kb upstream of the cap site to the first intron. The domain was flanked on bot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Uehara Y,Ono T,Kurishita A,Kokuryu H,Okada S

    更新日期:1989-08-01 00:00:00

  • Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.

    abstract::Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular endothelial cell growth factor (VEGF) is known to be one of the most important inducers of angiogenesis and is upregulated in carcinoma of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203817

    authors: López-Ocejo O,Viloria-Petit A,Bequet-Romero M,Mukhopadhyay D,Rak J,Kerbel RS

    更新日期:2000-09-21 00:00:00

  • Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition.

    abstract::Rapamycin, a natural product inhibitor of the Raptor-mammalian target of rapamycin complex (mTORC1), is known to induce Protein kinase B (Akt/PKB) Ser-473 phosphorylation in a subset of human cancer cell lines through inactivation of S6K1, stabilization of insulin receptor substrate (IRS)-1, and increased signaling th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210343

    authors: Han EK,Leverson JD,McGonigal T,Shah OJ,Woods KW,Hunter T,Giranda VL,Luo Y

    更新日期:2007-08-16 00:00:00

  • Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer.

    abstract::Resistance to anti-HER2 (human epithelial growth factor receptor 2) trastuzumab therapy occurs commonly in HER2-positive breast cancer and involves overactivation of HER2 and/or AKT1. Using the model of trastuzumab-sensitive or trastuzumab-resistant HER2-positive cells with wild-type PTEN, negative regulator of AKT1, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.422

    authors: Kulkarni S,Reddy KB,Esteva FJ,Moore HC,Budd GT,Tubbs RR

    更新日期:2010-03-04 00:00:00

  • Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach.

    abstract::Oncofetal genes are expressed in embryos or fetuses, are downregulated or undetectable in adult tissues, and then re-expressed in tumors. Known oncofetal genes, such as AFP, GCB, FGF18, IMP-1 and SOX1, often have important clinical applications or pivotal biological functions. To find new oncofetal-like genes, we used...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.451

    authors: Hsu CC,Chiang CW,Cheng HC,Chang WT,Chou CY,Tsai HW,Lee CT,Wu ZH,Lee TY,Chao A,Chow NH,Ho CL

    更新日期:2011-02-10 00:00:00

  • Polyoma small T antigen triggers cell death via mitotic catastrophe.

    abstract::Polyoma small T antigen (PyST), an early gene product of the polyoma virus, has been shown to cause cell death in a number of mammalian cells in a protein phosphatase 2A (PP2A)-dependent manner. In the current study, using a cell line featuring regulated expression of PyST, we found that PyST arrests cells in mitosis....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.192

    authors: Pores Fernando AT,Andrabi S,Cizmecioglu O,Zhu C,Livingston DM,Higgins JM,Schaffhausen BS,Roberts TM

    更新日期:2015-05-07 00:00:00

  • Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

    abstract::The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matrix remodeling factors, and might be implicated in disease progression of breast cancer. In the present study, the prognostic value of Ets-1 expression was assessed by quantitative real-time fluorescence RT-PCR in 123 sp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206040

    authors: Span PN,Manders P,Heuvel JJ,Thomas CM,Bosch RR,Beex LV,Sweep CG

    更新日期:2002-12-05 00:00:00

  • Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development.

    abstract::Mesoderm formation in the frog, Xenopus laevis, is dependent on the activity of one or more members of the Src family kinases; the molecular interactions underlying this requirement are not well understood. The C-terminal Src Kinase (Csk) is a potent inhibitor of Src activity, and is required for normal mammalian deve...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204672

    authors: Song Y,Cohler AN,Weinstein DC

    更新日期:2001-08-23 00:00:00

  • MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells.

    abstract::MEMO1 (mediator of ErbB2-driven cell motility 1) regulates HER2-dependent cell migration. Increased MEMO1 expression is associated with cancer aggressiveness. Here, we found that MEMO1 is also involved in breast carcinogenesis via regulating insulin-like growth factor-I receptor-dependent signaling events. We showed t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.327

    authors: Sorokin AV,Chen J

    更新日期:2013-06-27 00:00:00

  • BAG-1 accelerates cell motility of human gastric cancer cells.

    abstract::BAG-1 is a Hsp70/Hsc70-binding protein that interacts with Bcl-2, Raf-1, steroid hormone receptors, Siah-1, and hepatocyte growth factor (HGF) receptors, implying multiple functions for the BAG-1 protein. Here, we provide evidence that gene transfer-mediated overexpression of BAG-1 markedly enhances the motility of hu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202661

    authors: Naishiro Y,Adachi M,Okuda H,Yawata A,Mitaka T,Takayama S,Reed JC,Hinoda Y,Imai K

    更新日期:1999-05-27 00:00:00

  • HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

    abstract::Growth factor receptor-mediated signal transduction has been implicated in conferring resistance to conventional chemotherapy on cancer cells. In this study, we delineated a pathway that involves HER2/PI-3K/Akt in mediating multidrug resistance in human breast cancer cells. We found that the cell lines that express bo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206394

    authors: Knuefermann C,Lu Y,Liu B,Jin W,Liang K,Wu L,Schmidt M,Mills GB,Mendelsohn J,Fan Z

    更新日期:2003-05-22 00:00:00

  • Beyond the RING: CBL proteins as multivalent adapters.

    abstract::Following discovery of c-Cbl, a cellular form of the transforming retroviral protein v-Cbl, multiple Cbl-related proteins have been identified in vertebrate and invertebrate organisms. c-Cbl and its homologues are capable of interacting with numerous proteins involved in cell signaling, including various molecular ada...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204781

    authors: Tsygankov AY,Teckchandani AM,Feshchenko EA,Swaminathan G

    更新日期:2001-10-01 00:00:00

  • Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.

    abstract::Retinoic Acid (RA) treatment induces disease remission of Acute Promyelocytic Leukaemia (APL) patients by triggering terminal differentiation of neoplastic cells. RA-sensitivity in APL is mediated by its oncogenic protein, which results from the recombination of the PML and the RA receptor alpha (RAR alpha) genes (PML...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203029

    authors: Grignani F,Gelmetti V,Fanelli M,Rogaia D,De Matteis S,Ferrara FF,Bonci D,Grignani F,Nervi C,Pelicci PG

    更新日期:1999-11-04 00:00:00

  • G2A is an oncogenic G protein-coupled receptor.

    abstract::G2A is a heptahelical cell surface protein that has recently been described as a potential tumor suppressor, based on its ability to counteract transformation of pre-B cells and fibroblasts by Bcr-Abl, an oncogenic tyrosine kinase. We have isolated cDNAs encoding G2A in the course of screening libraries for clones tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203731

    authors: Zohn IE,Klinger M,Karp X,Kirk H,Symons M,Chrzanowska-Wodnicka M,Der CJ,Kay RJ

    更新日期:2000-08-10 00:00:00

  • Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).

    abstract::Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recogni...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203943

    authors: Hosaka T,Kanoe H,Nakayama T,Murakami H,Yamamoto H,Nakamata T,Tsuboyama T,Oka M,Kasai M,Sasaki MS,Nakamura T,Toguchida J

    更新日期:2000-11-23 00:00:00

  • Induction of telomerase activity by UV-irradiation in Chinese hamster cells.

    abstract::Telomerase is a ribonucleoprotein whose activity has been detected in germline cells and in neoplastic and immortal cells. Telomerase compensates the telomere loss arising by the end replication problem by synthesizing telomeric repeats at the 3' end of the eukaryotic chromosomes. Telomerase is reactivated during canc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201327

    authors: Hande MP,Balajee AS,Natarajan AT

    更新日期:1997-10-02 00:00:00

  • A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer.

    abstract::Elucidation of mechanisms underlying the increased androgen receptor (AR) activity and subsequent development of aggressive prostate cancer (PrCa) is pivotal in developing new therapies. Using a systems biology approach, we interrogated the AR-regulated proteome and identified PDZ binding kinase (PBK) as a novel AR-re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0501-z

    authors: Warren AY,Massie CE,Watt K,Luko K,Orafidiya F,Selth LA,Mohammed H,Chohan BS,Menon S,Baridi A,Zhao W,Escriu C,Pungsrinont T,D'Santos C,Yang X,Taylor C,Qureshi A,Zecchini VR,Shaw GL,Dehm SM,Mills IG,Carroll JS,T

    更新日期:2019-02-01 00:00:00

  • In vitro reconstruction of tumour initiation in a human epithelium.

    abstract::Knowledge of tumour initiation in human epithelia is limited by sample availability and difficulty in experimental manipulation of human cells. The thyroid is a useful model since, in addition to multiple tumour stages, it presents two distinct 'pathways' of tumorigenesis: 'follicular' tumours, in which ras oncogene m...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bond JA,Wyllie FS,Rowson J,Radulescu A,Wynford-Thomas D

    更新日期:1994-01-01 00:00:00

  • RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789.

    abstract::FGFR1 (fibroblast growth factor receptor 1) regulates many key cellular responses including proliferation, migration and differentiation through activation of signaling pathways. Irregularities in FGFR1 signaling have been implicated in several pathological conditions, including human cancer. In order to discover nove...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.425

    authors: Nadratowska-Wesolowska B,Haugsten EM,Zakrzewska M,Jakimowicz P,Zhen Y,Pajdzik D,Wesche J,Wiedlocha A

    更新日期:2014-10-02 00:00:00

  • Mutations of the p16 gene in gliomas.

    abstract::In the present study we investigated the frequency of p16 gene exon 2 mutations in 35 malignant gliomas, using either direct sequencing of the PCR products or cloning into the pCRII vector and sequencing of the cloned PCR products. No mutations were detected during direct sequencing of the PCR products. However, after...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kyritsis AP,Zhang B,Zhang W,Xiao M,Takeshima H,Bondy ML,Cunningham JE,Levin VA,Bruner J

    更新日期:1996-01-04 00:00:00

  • MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.

    abstract::One-carbon metabolism plays a central role in a broad array of metabolic processes required for the survival and growth of tumor cells. However, the molecular basis of how one-carbon metabolism may influence RNA methylation and tumorigenesis remains largely unknown. Here we show MTHFD2, a mitochondrial enzyme involved...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0869-4

    authors: Green NH,Galvan DL,Badal SS,Chang BH,LeBleu VS,Long J,Jonasch E,Danesh FR

    更新日期:2019-08-01 00:00:00

  • Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.

    abstract::The clonality of lymphomas that originate in myc/pim-1 bitransgenic mice due to synergistic action of both oncogenes indicates the requirement of additional events for progression to full malignancy. To isolate genes that cooperate with both myc and pim-1, we have used provirus tagging with E mu L-myc/pim-1 double tra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zörnig M,Schmidt T,Karsunky H,Grzeschiczek A,Möröy T

    更新日期:1996-04-18 00:00:00

  • SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment.

    abstract::L-ascorbate (L-ascorbic acid, vitamin C) clearly has an inhibitory effect on cancer cells. However, the mechanism underlying differential sensitivity of cancer cells from same tissue to L-ascorbate is yet to be clarified. Here, we demonstrate that L-ascorbate has a selective killing effect, which is influenced by sodi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.176

    authors: Hong SW,Lee SH,Moon JH,Hwang JJ,Kim DE,Ko E,Kim HS,Cho IJ,Kang JS,Kim DJ,Kim JE,Shin JS,Jung DJ,Jeong YJ,Cho BJ,Kim TW,Lee JS,Kang JS,Hwang YI,Noh DY,Jin DH,Lee WJ

    更新日期:2013-03-21 00:00:00